• Skip to main content
  • Skip to footer

GBT Pharma

Experts in OTC market access

  • Our Services
    • International Business Development
    • International Product Development
  • Our Products
    • cannaQIX
    • Klear-vol
    • Estroplus Meno Manage
    • Pediatra Suizo
    • Estroplus™
    • Phytovir®
    • Similasan®
    • Kwai
    • Kira
  • About GBT Pharma
    • Company History
  • GBT Pharma Clients
  • The GBT Pharma Team
    • Our Team in Switzerland
    • Our Team in Latin America
    • Our Team in the UK
  • News
  • Contact Us

June 2, 2017 By Heather Scott

Consumer focus helps Similasan climb in the Netherlands

Read how a consumer-centric approach and focus on brand development helped Similasan become the third-largest eye-care brand in the Netherlands in less than a year.

“Our objective remains to make the Similsan brand available in every pharmacy in the Netherlands,” says Harm-Jan Schuurman head of the Swiss homeopathic firm’s dutch subsidiary. Read more about the brand’s growth plans in this feature from OTC Bulletin.

Filed Under: News

Footer

Contact Us

Rte de la Vignettaz 25 |

1700 Fribourg |

Switzerland |

Tel: + 41 79 262 60 43

gian.trepp@gbtpharma.com

About Us

We specialize in developing international markets for our clients. As your partner in driving international growth, GBT Pharma works to quickly understand your business and its objectives.

Follow Us

  • LinkedIn

Copyright © 2025 · GBT Pharma